🇺🇸 radiochemotherapy in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 10
Most-reported reactions
- Anaemia — 1 report (10%)
- Aortic Aneurysm — 1 report (10%)
- Arrhythmia — 1 report (10%)
- Arteriosclerosis — 1 report (10%)
- Arteriosclerosis Coronary Artery — 1 report (10%)
- C-Reactive Protein Increased — 1 report (10%)
- Cardiac Failure — 1 report (10%)
- Cardiac Failure Congestive — 1 report (10%)
- Diarrhoea — 1 report (10%)
- Hepatic Congestion — 1 report (10%)
Other Other approved in United States
Frequently asked questions
Is radiochemotherapy approved in United States?
radiochemotherapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for radiochemotherapy in United States?
Federation Francophone de Cancerologie Digestive is the originator. The local marketing authorisation holder may differ — check the official source linked above.